Sarah E. Holden

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls

Christian Bannister, Sarah E. Holden, Sara Jenkins‐Jones et al. · Diabetes Obesity and Metabolism · 2014 · 354 citations

Medicine, Pharmacology, Pharmacotherapy +17

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010

Sarah E. Holden, Anthony Barnett, John R. Peters et al. · Diabetes Obesity and Metabolism · 2013 · 124 citations

Medicine, Endocrinology, Internal Medicine +13

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)

Sarah E. Holden, Sara Jenkins‐Jones, Chris Poole et al. · Child and Adolescent Psychiatry and Mental Health · 2013 · 89 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia

Sara Jenkins‐Jones, Lotta Parviainen, John B. Porter et al. · European Journal of Endocrinology · 2018 · 84 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +14

Combination therapy with metformin plus sulphonylureas versus metformin plus <scp>DPP</scp> ‐4 inhibitors: association with major adverse cardiovascular events and all‐cause mortality

C. Ll. Morgan, Jayanti Mukherjee, Sara Jenkins‐Jones et al. · Diabetes Obesity and Metabolism · 2014 · 76 citations

Pharmacy, Pharmacology, Pharmacotherapy +16